Literature DB >> 625061

Evidence for a proliferative advantage of human leukemia colony-forming cells in vitro.

H E Broxmeyer, E Grossbard, N Jacobsen, M A Moore.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 625061     DOI： 10.1093/jnci/60.3.513

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Production, characteristics and mode of action of hemopoietic growth inhibitors in myeloid leukemias.

Authors:  I Olsson; T Olofsson
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

2.  Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production.

Authors:  H E Broxmeyer; A Smithyman; R R Eger; P A Meyers; M de Sousa
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

3.  HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.

Authors:  H E Broxmeyer; L Juliano; L Lu; E Platzer; B Dupont
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

4.  Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages.

Authors:  H E Broxmeyer; J Bognacki; M H Dorner; M de Sousa
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

5.  Relationship of cell-cycle expression of Ia-like antigenic determinants on normal and leukemia human granulocyte-macrophage progenitor cells to regulation in vitro by acidic isoferritins.

Authors:  H E Broxmeyer
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

6.  DPP4 truncated GM-CSF and IL-3 manifest distinct receptor-binding and regulatory functions compared with their full-length forms.

Authors:  H A O'Leary; M Capitano; S Cooper; C Mantel; H S Boswell; R Kapur; B Ramdas; R Chan; L Deng; C-K Qu; H E Broxmeyer
Journal:  Leukemia       Date:  2017-03-27       Impact factor: 11.528
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.